pharmacie et médicaments – Prise en charge des traitements innovants contre la migraine chronique sévère

This written question asks about the coverage of innovative treatments for severe chronic migraine. It seeks to understand the current policies and potential future approaches to ensure patients have access to these new therapies. The question affects patients suffering from severe chronic migraine and healthcare providers. It could lead to changes in reimbursement policies for advanced medical treatments.